PDGFRA one nucleotide deletion: A novel mutation of systemic mastocytosis associated with chronic myelomonocytic leukemia

Yi Ying Wu, Su wen Nieh, Li Tzong Chen, Hubert Chan, Lai Fa Sheu, Tsu Yi Chao, Yeu Chin Chen

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: The mast cell is a common tissue cell located in connective tissue around blood vessels and beneath the capsular tissues of most organs. Uncontrolled proliferation can lead to mast cell disease, which may have different clinical presentation depending on site of primary involvement. Recently, a point mutation in the c-kit receptor gene, Asp816Val (D816V), was shown to activate c-kit, via ligand-independent receptor autophosphorylation resulting in uncontrolled mast cell proliferation. Fusion gene involving Fip1-like 1(FIPL1L1) and plateletderived growth factor receptorα (PDGFRA) was identified in hypereosinophilic syndrome (HES) and mast cell disease. These mutations might have quite different treatment response to imatinib mesylate. Case Report: A 71-year-old man presented with intractable ascites, hepatosplenomegaly, and skin ecchymosis change. Laboratory tests showed leukocytosis, monocytosis, and anemia. Histopathological examination of bone marrow, liver, skin, and ascites all showed spindle-shaped mast cells infiltration. Gene mutation analysis revealed one nucleotide deletion in PDGFRA exon18; the frame-shift generating a new mutated protein. The patient was treated with hydroxyurea. His ascites and leukocytosis were under controlled. Conclusions: Systemic mastocytosis should be considered as one cause of ascites, especially in those patients with unexplained hepatomegaly and splenomegaly. Genetic analysis is crucial in this kind of cases in order to determine the treatment strategy and evaluate patients' prognosis.

Original languageEnglish
Pages (from-to)10-14
Number of pages5
JournalAmerican Journal of Case Reports
Volume9
Publication statusPublished - 2008
Externally publishedYes

Fingerprint

Leukemia, Myelomonocytic, Chronic
Systemic Mastocytosis
Ascites
Nucleotides
Mast Cells
Mastocytosis
Mutation
Leukocytosis
Proto-Oncogene Proteins c-kit
Ecchymosis
Hypereosinophilic Syndrome
Bone Marrow Examination
Skin
Stem Cell Factor
Hepatomegaly
Hydroxyurea
Growth Factor Receptors
Gene Fusion
Splenomegaly
Point Mutation

Keywords

  • Chronic myelomonocytic leukemia
  • Hepatosplenomegaly
  • Platelet-derived growth factor receptorα [PDGFRA]
  • Systemic mastocytosis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

PDGFRA one nucleotide deletion : A novel mutation of systemic mastocytosis associated with chronic myelomonocytic leukemia. / Wu, Yi Ying; Nieh, Su wen; Chen, Li Tzong; Chan, Hubert; Sheu, Lai Fa; Chao, Tsu Yi; Chen, Yeu Chin.

In: American Journal of Case Reports, Vol. 9, 2008, p. 10-14.

Research output: Contribution to journalArticle

Wu, Yi Ying ; Nieh, Su wen ; Chen, Li Tzong ; Chan, Hubert ; Sheu, Lai Fa ; Chao, Tsu Yi ; Chen, Yeu Chin. / PDGFRA one nucleotide deletion : A novel mutation of systemic mastocytosis associated with chronic myelomonocytic leukemia. In: American Journal of Case Reports. 2008 ; Vol. 9. pp. 10-14.
@article{6a1cbdfdc5f14bc5a228962e5aee0788,
title = "PDGFRA one nucleotide deletion: A novel mutation of systemic mastocytosis associated with chronic myelomonocytic leukemia",
abstract = "Background: The mast cell is a common tissue cell located in connective tissue around blood vessels and beneath the capsular tissues of most organs. Uncontrolled proliferation can lead to mast cell disease, which may have different clinical presentation depending on site of primary involvement. Recently, a point mutation in the c-kit receptor gene, Asp816Val (D816V), was shown to activate c-kit, via ligand-independent receptor autophosphorylation resulting in uncontrolled mast cell proliferation. Fusion gene involving Fip1-like 1(FIPL1L1) and plateletderived growth factor receptorα (PDGFRA) was identified in hypereosinophilic syndrome (HES) and mast cell disease. These mutations might have quite different treatment response to imatinib mesylate. Case Report: A 71-year-old man presented with intractable ascites, hepatosplenomegaly, and skin ecchymosis change. Laboratory tests showed leukocytosis, monocytosis, and anemia. Histopathological examination of bone marrow, liver, skin, and ascites all showed spindle-shaped mast cells infiltration. Gene mutation analysis revealed one nucleotide deletion in PDGFRA exon18; the frame-shift generating a new mutated protein. The patient was treated with hydroxyurea. His ascites and leukocytosis were under controlled. Conclusions: Systemic mastocytosis should be considered as one cause of ascites, especially in those patients with unexplained hepatomegaly and splenomegaly. Genetic analysis is crucial in this kind of cases in order to determine the treatment strategy and evaluate patients' prognosis.",
keywords = "Chronic myelomonocytic leukemia, Hepatosplenomegaly, Platelet-derived growth factor receptorα [PDGFRA], Systemic mastocytosis",
author = "Wu, {Yi Ying} and Nieh, {Su wen} and Chen, {Li Tzong} and Hubert Chan and Sheu, {Lai Fa} and Chao, {Tsu Yi} and Chen, {Yeu Chin}",
year = "2008",
language = "English",
volume = "9",
pages = "10--14",
journal = "American Journal of Case Reports",
issn = "1941-5923",
publisher = "International Scientific Literature, Inc",

}

TY - JOUR

T1 - PDGFRA one nucleotide deletion

T2 - A novel mutation of systemic mastocytosis associated with chronic myelomonocytic leukemia

AU - Wu, Yi Ying

AU - Nieh, Su wen

AU - Chen, Li Tzong

AU - Chan, Hubert

AU - Sheu, Lai Fa

AU - Chao, Tsu Yi

AU - Chen, Yeu Chin

PY - 2008

Y1 - 2008

N2 - Background: The mast cell is a common tissue cell located in connective tissue around blood vessels and beneath the capsular tissues of most organs. Uncontrolled proliferation can lead to mast cell disease, which may have different clinical presentation depending on site of primary involvement. Recently, a point mutation in the c-kit receptor gene, Asp816Val (D816V), was shown to activate c-kit, via ligand-independent receptor autophosphorylation resulting in uncontrolled mast cell proliferation. Fusion gene involving Fip1-like 1(FIPL1L1) and plateletderived growth factor receptorα (PDGFRA) was identified in hypereosinophilic syndrome (HES) and mast cell disease. These mutations might have quite different treatment response to imatinib mesylate. Case Report: A 71-year-old man presented with intractable ascites, hepatosplenomegaly, and skin ecchymosis change. Laboratory tests showed leukocytosis, monocytosis, and anemia. Histopathological examination of bone marrow, liver, skin, and ascites all showed spindle-shaped mast cells infiltration. Gene mutation analysis revealed one nucleotide deletion in PDGFRA exon18; the frame-shift generating a new mutated protein. The patient was treated with hydroxyurea. His ascites and leukocytosis were under controlled. Conclusions: Systemic mastocytosis should be considered as one cause of ascites, especially in those patients with unexplained hepatomegaly and splenomegaly. Genetic analysis is crucial in this kind of cases in order to determine the treatment strategy and evaluate patients' prognosis.

AB - Background: The mast cell is a common tissue cell located in connective tissue around blood vessels and beneath the capsular tissues of most organs. Uncontrolled proliferation can lead to mast cell disease, which may have different clinical presentation depending on site of primary involvement. Recently, a point mutation in the c-kit receptor gene, Asp816Val (D816V), was shown to activate c-kit, via ligand-independent receptor autophosphorylation resulting in uncontrolled mast cell proliferation. Fusion gene involving Fip1-like 1(FIPL1L1) and plateletderived growth factor receptorα (PDGFRA) was identified in hypereosinophilic syndrome (HES) and mast cell disease. These mutations might have quite different treatment response to imatinib mesylate. Case Report: A 71-year-old man presented with intractable ascites, hepatosplenomegaly, and skin ecchymosis change. Laboratory tests showed leukocytosis, monocytosis, and anemia. Histopathological examination of bone marrow, liver, skin, and ascites all showed spindle-shaped mast cells infiltration. Gene mutation analysis revealed one nucleotide deletion in PDGFRA exon18; the frame-shift generating a new mutated protein. The patient was treated with hydroxyurea. His ascites and leukocytosis were under controlled. Conclusions: Systemic mastocytosis should be considered as one cause of ascites, especially in those patients with unexplained hepatomegaly and splenomegaly. Genetic analysis is crucial in this kind of cases in order to determine the treatment strategy and evaluate patients' prognosis.

KW - Chronic myelomonocytic leukemia

KW - Hepatosplenomegaly

KW - Platelet-derived growth factor receptorα [PDGFRA]

KW - Systemic mastocytosis

UR - http://www.scopus.com/inward/record.url?scp=78249235645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78249235645&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:78249235645

VL - 9

SP - 10

EP - 14

JO - American Journal of Case Reports

JF - American Journal of Case Reports

SN - 1941-5923

ER -